Accelerating drug discovery for pregnant and lactating women living with HIV.
作者信息
Hoffman Risa M, Mngqibisa Rosie, Averitt Dawn, Currier Judith S
机构信息
Department of Medicine and Division of Infectious Diseases, David Geffen School of Medicine at the University of California, Los Angeles, CA, USA.
Durban International Clinical Research Site, Enhancing Care Foundation, Durban, South Africa.
出版信息
J Int AIDS Soc. 2021 Mar;24(3):e25680. doi: 10.1002/jia2.25680.
Abstract
摘要
相似文献
1
Accelerating drug discovery for pregnant and lactating women living with HIV.
J Int AIDS Soc. 2021 Mar;24(3):e25680. doi: 10.1002/jia2.25680.
2
Factors associated with knowledge of pre-exposure prophylaxis in pregnant women in Cape Town, South Africa.
Int J STD AIDS. 2019 Oct;30(11):1063-1070. doi: 10.1177/0956462419863216. Epub 2019 Aug 28.
3
Performing Drug Safety Research During Pregnancy and Lactation: Biomedical HIV Prevention Research as a Template.
J Womens Health (Larchmt). 2016 Jul;25(7):761-6. doi: 10.1089/jwh.2013.4398. Epub 2013 Jun 29.
4
Engaging the community of women living with HIV to tailor and accelerate ARV research for pregnant and breastfeeding women.
J Int AIDS Soc. 2022 Jul;25 Suppl 2(Suppl 2):e25920. doi: 10.1002/jia2.25920.
5
Stigma, Facility Constraints, and Personal Disbelief: Why Women Disengage from HIV Care During and After Pregnancy in Morogoro Region, Tanzania.
AIDS Behav. 2017 Jan;21(1):317-329. doi: 10.1007/s10461-016-1505-8.
6
Point/counterpoint: II. The case against mandatory prenatal HIV testing.
Obstet Gynecol Surv. 1995 Jan;50(1):2-3. doi: 10.1097/00006254-199501000-00002.
7
Disrupting the status quo to achieve early inclusion of pregnant women in studies of new agents for prevention and treatment of HIV infection.
J Int AIDS Soc. 2022 Jul;25 Suppl 2(Suppl 2):e25927. doi: 10.1002/jia2.25927.
8
Assessing the Impact of Perinatal HIV Case Management on Outcomes Along the HIV Care Continuum for Pregnant and Postpartum Women Living With HIV, Philadelphia 2005-2013.
AIDS Behav. 2017 Sep;21(9):2670-2681. doi: 10.1007/s10461-017-1714-9.
9
Short (and shorter) courses of zidovudine.
N Engl J Med. 1998 Nov 12;339(20):1467-8. doi: 10.1056/NEJM199811123392009.
10
Should research ethics change at the border?
Med J Aust. 1998 Nov 16;169(10):509-10.
引用本文的文献
1
Vulnerability in Biomedical Research: A Historical Reflection and Practical Implications for HIV Cure-Related Research.
AIDS Res Hum Retroviruses. 2024 Jan;40(1):22-27. doi: 10.1089/AID.2022.0136. Epub 2023 Jun 21.
2
Pharmacokinetic data in pregnancy: A review of available literature data and important considerations in collecting clinical data.
Front Med (Lausanne). 2022 Oct 4;9:940644. doi: 10.3389/fmed.2022.940644. eCollection 2022.
3
Where are the pregnant and breastfeeding women in new pre-exposure prophylaxis trials? The imperative to overcome the evidence gap.
Lancet HIV. 2022 Mar;9(3):e214-e222. doi: 10.1016/S2352-3018(21)00280-0. Epub 2022 Jan 25.
4
Ending the evidence gap for pregnancy, HIV and co-infections: ethics guidance from the PHASES project.
J Int AIDS Soc. 2021 Dec;24(12):e25846. doi: 10.1002/jia2.25846.
本文引用的文献
1
Adaptive platform trials: definition, design, conduct and reporting considerations.
Nat Rev Drug Discov. 2019 Oct;18(10):797-807. doi: 10.1038/s41573-019-0034-3. Epub 2019 Aug 28.
2
Importance of Prospective Studies in Pregnant and Breastfeeding Women Living With Human Immunodeficiency Virus.
Clin Infect Dis. 2019 Sep 13;69(7):1254-1258. doi: 10.1093/cid/ciz121.
Zotero 插件